Sensory Disorders
Idiopathic Sudden Sensorineural Hearing Loss
This is an unexplained, rapid loss of hearing thought to involve reduced oxygen supply to the inner ear. Hyperbaric oxygen therapy is FDA-approved as an adjunct — typically when corticosteroids alone fail — reversing cochlear hypoxia and reducing endolymphatic fluid pressure to improve the chance of hearing recovery.
Evidence Level B Standard of Care
Treatment protocol
Protocol
Pressure
2.0 – 2.5 ATA
Duration
90 min
Sessions
10 – 20
Frequency
Once daily, 5×/week
Evidence basis: UHMS / Standard of Care
References:
See full citations on the references page.
Last updated: